JP2005525317A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005525317A5 JP2005525317A5 JP2003561517A JP2003561517A JP2005525317A5 JP 2005525317 A5 JP2005525317 A5 JP 2005525317A5 JP 2003561517 A JP2003561517 A JP 2003561517A JP 2003561517 A JP2003561517 A JP 2003561517A JP 2005525317 A5 JP2005525317 A5 JP 2005525317A5
- Authority
- JP
- Japan
- Prior art keywords
- kit
- dose
- administered
- total weekly
- times per
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34915802P | 2002-01-18 | 2002-01-18 | |
| PCT/US2003/001394 WO2003061571A2 (en) | 2002-01-18 | 2003-01-18 | Combination il-2/anti-herz antibody therapy for cancers characterized by overexpression of the her2 receptor protein |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005525317A JP2005525317A (ja) | 2005-08-25 |
| JP2005525317A5 true JP2005525317A5 (https=) | 2006-03-02 |
Family
ID=27613252
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003561517A Withdrawn JP2005525317A (ja) | 2002-01-18 | 2003-01-18 | Ｈｅｒ２レセプタータンパク質の過剰発現によって特徴づけられる癌のための組み合わせｉｌ−２／抗ｈｅｒ２抗体治療 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20030235556A1 (https=) |
| EP (1) | EP1569689A4 (https=) |
| JP (1) | JP2005525317A (https=) |
| AU (1) | AU2003210549A1 (https=) |
| CA (1) | CA2472186A1 (https=) |
| WO (1) | WO2003061571A2 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7625859B1 (en) | 2000-02-16 | 2009-12-01 | Oregon Health & Science University | HER-2 binding antagonists |
| US7393823B1 (en) | 1999-01-20 | 2008-07-01 | Oregon Health And Science University | HER-2 binding antagonists |
| US7306801B2 (en) * | 2000-05-15 | 2007-12-11 | Health Research, Inc. | Methods of therapy for cancers characterized by overexpression of the HER2 receptor protein |
| BRPI0508470A (pt) * | 2004-03-05 | 2007-07-31 | Chiron Corp | sistema de teste in vitro para prever toleráncia do paciente aos agentes terapêuticos |
| WO2006042002A2 (en) * | 2004-10-05 | 2006-04-20 | Oregon Health And Science University | Compositions and methods for treating disease |
| CN102159236A (zh) | 2008-07-17 | 2011-08-17 | 阿索尔达治疗公司 | 用于治疗或预防心力衰竭的神经调节蛋白或其亚序列的治疗性施剂 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4894227A (en) * | 1986-08-01 | 1990-01-16 | Cetus Corporation | Composition of immunotoxins with interleukin-2 |
| WO1989006692A1 (en) * | 1988-01-12 | 1989-07-27 | Genentech, Inc. | Method of treating tumor cells by inhibiting growth factor receptor function |
| US6921530B1 (en) * | 1999-09-24 | 2005-07-26 | Cornell Research Foundation, Inc. | Low dose IL-2 for potentiation of immunity |
| US7306801B2 (en) * | 2000-05-15 | 2007-12-11 | Health Research, Inc. | Methods of therapy for cancers characterized by overexpression of the HER2 receptor protein |
-
2003
- 2003-01-18 EP EP03731950A patent/EP1569689A4/en not_active Withdrawn
- 2003-01-18 AU AU2003210549A patent/AU2003210549A1/en not_active Abandoned
- 2003-01-18 CA CA002472186A patent/CA2472186A1/en not_active Abandoned
- 2003-01-18 JP JP2003561517A patent/JP2005525317A/ja not_active Withdrawn
- 2003-01-18 US US10/346,468 patent/US20030235556A1/en not_active Abandoned
- 2003-01-18 WO PCT/US2003/001394 patent/WO2003061571A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6878524B2 (ja) | Ｉｌ−１７抗体の医薬製品および安定した液体組成物 | |
| TWI548419B (zh) | 利用ｉｌ－１７拮抗劑治療牛皮癬的方法 | |
| JP2004501101A5 (https=) | ||
| JP2007512243A5 (https=) | ||
| HRP20210876T1 (hr) | Anti-tmprss2 antitijela i fragmenti koji vezuju antigen | |
| JP2003528155A5 (https=) | ||
| JP2014114288A5 (https=) | ||
| RU2006120950A (ru) | Антитело к cd40: препарат и способы | |
| RU2017107559A (ru) | Лечение раковых заболеваний с применением анти-nkg2a средств | |
| JP2013543501A5 (https=) | ||
| JP2005538034A5 (https=) | ||
| RU2009149294A (ru) | Антиген-связывающие белки, нацеленные на orf0657n s.aureus | |
| EP2468302A1 (en) | New indications for anti-IL-1beta therapy | |
| KR20060023968A (ko) | 중증 급성 호흡기 증후군(ｓａｒｓ)의 치료를 위한 조성물및 방법 | |
| CA2290021A1 (en) | Suppression of tumor necrosis factor alpha and vascular endothelial growth factor in therapy | |
| JP2018515493A5 (https=) | ||
| WO2007050607A2 (en) | Novel use of il-1beta compounds | |
| JP2005525317A5 (https=) | ||
| JP2021523881A5 (https=) | ||
| CA3123024A1 (en) | Compositions and methods for enhancing body weight and lean muscle mass using antagonists against leptin receptor, gdf8 and activin a | |
| JPWO2021054867A5 (https=) | ||
| CN119587691A (zh) | 抗her2抗体药物偶联物联合抗her2抗体治疗肿瘤 | |
| CN113316587A (zh) | 一种双特异性分子及其制备与用途 | |
| AU2012203931B2 (en) | New indications for anti-IL-I-beta therapy | |
| WO2003061571A3 (en) | Combination il-2/anti-herz antibody therapy for cancers characterized by overexpression of the her2 receptor protein |